Compare AGX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGX | WGS |
|---|---|---|
| Founded | 1961 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.6B |
| IPO Year | N/A | N/A |
| Metric | AGX | WGS |
|---|---|---|
| Price | $318.43 | $150.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $321.00 | $135.00 |
| AVG Volume (30 Days) | 451.3K | ★ 453.1K |
| Earning Date | 12-04-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.63% | N/A |
| EPS Growth | ★ 76.74 | N/A |
| EPS | ★ 8.49 | 0.07 |
| Revenue | ★ $915,030,000.00 | $402,190,000.00 |
| Revenue This Year | $11.43 | $41.17 |
| Revenue Next Year | $18.27 | $23.53 |
| P/E Ratio | ★ $37.66 | $2,102.42 |
| Revenue Growth | 13.49 | ★ 50.50 |
| 52 Week Low | $101.02 | $55.17 |
| 52 Week High | $399.30 | $170.87 |
| Indicator | AGX | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 44.86 | 51.53 |
| Support Level | $307.64 | $156.17 |
| Resistance Level | $341.00 | $165.62 |
| Average True Range (ATR) | 19.75 | 7.38 |
| MACD | -6.71 | -1.80 |
| Stochastic Oscillator | 35.37 | 11.25 |
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.